we established an indirect ELISA method to detect anti- Mycobacterium tuberculosis IgM and IgG. We tested 453 sera and analyzed the efficacy of the protein candidates for diagnosis of tuberculosis.

It intended for the quantitative detection of human IgG antibodies to Mycobacterium tuberculosis in serum, plasma or cerebrospinal fluid (CSF) within 100 minutes

201-300 sero unit

The ELISA (Enzyme-Linked Immunosorbent Assay) test for Anti-TB (Tuberculosis) IgG antibodies is used to detect the presence of IgG antibodies specific to Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Here's how to interpret the results: Positive Result: A positive ELISA result indicates the presence of IgG antibodies specific to Mycobacterium tuberculosis in the blood sample. Interpretation: A positive result suggests exposure to Mycobacterium tuberculosis and the development of an immune response. IgG antibodies are typically produced during the later stages of infection or following vaccination against tuberculosis. A positive result may indicate latent tuberculosis infection (LTBI) or active tuberculosis disease, depending on the individual's clinical presentation, risk factors, and other diagnostic findings. Negative Result: A negative ELISA result indicates the absence of detectable IgG antibodies specific to Mycobacterium tuberculosis in the blood sample. Interpretation: A negative result may occur if the individual has not been exposed to Mycobacterium tuberculosis or if the test is performed during the early stages of infection before IgG antibodies develop. In individuals with compromised immune systems, antibody production may be delayed or suppressed, leading to a false-negative result. Clinical Correlation: Interpretation of ELISA test results should be done in conjunction with the patient's clinical history, symptoms, exposure to tuberculosis, and other diagnostic tests (such as chest imaging and microbiological tests). A positive result, along with compatible clinical symptoms, risk factors, and other supportive diagnostic findings, may support a diagnosis of latent tuberculosis infection (LTBI) or active tuberculosis disease. A negative result does not rule out tuberculosis, particularly in individuals with high clinical suspicion or risk factors for tuberculosis. Confirmation and Further Testing: In cases where clinical suspicion of tuberculosis is high despite a negative ELISA result, additional testing may be warranted. Additional tests, such as tuberculin skin test (TST or Mantoux test), interferon-gamma release assays (IGRAs), sputum smear microscopy, culture, molecular tests (e.g., PCR), or imaging studies (such as chest X-ray or CT scan), may help confirm the diagnosis and guide treatment. Limitations: It's important to recognize that the ELISA test for Anti-TB IgG antibodies has limitations, including the potential for false-positive or false-negative results. False-positive results may occur due to cross-reactivity with antibodies against other mycobacteria or non-tuberculous mycobacteria (NTM). False-negative results may occur if the test is performed during the early stages of infection before IgG antibody production or if the patient has an impaired immune response. Interpretation of the ELISA test for Anti-TB IgG antibodies should be performed by healthcare providers experienced in the diagnosis and management of tuberculosis. It's essential to consider the clinical context, symptoms, risk factors, and potential limitations of the test when interpreting results and determining appropriate treatment and management strategies.

Blood